{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T19:15:24Z","timestamp":1771269324625,"version":"3.50.1"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T00:00:00Z","timestamp":1600992000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T00:00:00Z","timestamp":1600992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Saf"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s40264-020-01000-8","type":"journal-article","created":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T20:02:26Z","timestamp":1601064146000},"page":"1309-1314","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Sex Differences in Reported Adverse Drug Reactions to COVID-19 Drugs in a Global Database of Individual Case Safety Reports"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0297-8881","authenticated-orcid":false,"given":"Alem","family":"Zekarias","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9660-5968","authenticated-orcid":false,"given":"Sarah","family":"Watson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1619-3751","authenticated-orcid":false,"given":"Sara Hedfors","family":"Vidlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2799-9374","authenticated-orcid":false,"given":"Birgitta","family":"Grundmark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,25]]},"reference":[{"key":"1000_CR1","first-page":"11","volume":"7","author":"Y-R Guo","year":"2020","unstructured":"Guo Y-R, Cao Q-D, Hong Z-S, Tan Y-Y, Chen S-D, Jin H-J, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak\u2014an update on the status. Mil Med Res. 2020;7:11.","journal-title":"Mil Med Res."},{"key":"1000_CR2","unstructured":"WHO. Coronavirus disease (COVID-2019) situation reports. 2020. January 31 [Internet]. https:\/\/www.who.int\/docs\/default-source\/coronaviruse\/situation-reports\/20200131-sitrep-11-ncov.pdf?sfvrsn=de7c0f7_4. Accessed 11 June 2020."},{"key":"1000_CR3","unstructured":"COVID-19 dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU) [Internet]. https:\/\/www.arcgis.com\/apps\/opsdashboard\/index.html#\/bda7594740fd40299423467b48e9ecf6. Accessed 12 June 2020."},{"key":"1000_CR4","unstructured":"\u201cSolidarity\u201d clinical trial for COVID-19 treatments [Internet]. https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/global-research-on-novel-coronavirus-2019-ncov\/solidarity-clinical-trial-for-covid-19-treatments. Accessed 10 Aug 2020."},{"key":"1000_CR5","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13293-020-00304-9","volume":"11","author":"C Gebhard","year":"2020","unstructured":"Gebhard C, Regitz-Zagrosek V, Neuhauser HK, Morgan R, Klein SL. Impact of sex and gender on COVID-19 outcomes in Europe. Biol Sex Differ. 2020;11:29.","journal-title":"Biol Sex Differ."},{"key":"1000_CR6","doi-asserted-by":"publisher","first-page":"152","DOI":"10.3389\/fpubh.2020.00152","volume":"8","author":"J-M Jin","year":"2020","unstructured":"Jin J-M, Bai P, He W, Wu F, Liu X-F, Han D-M, et al. Gender differences in patients with COVID-19: focus on severity and mortality. Front Public Health. 2020;8:152.","journal-title":"Front Public Health."},{"key":"1000_CR7","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.maturitas.2020.05.009","volume":"138","author":"S Rozenberg","year":"2020","unstructured":"Rozenberg S, Vandromme J, Charlotte M. Are we equal in adversity? Does Covid-19 affect women and men differently? Maturitas. 2020;138:62\u20138.","journal-title":"Maturitas."},{"key":"1000_CR8","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1056\/NEJMoa030747","volume":"348","author":"C Drosten","year":"2003","unstructured":"Drosten C, G\u00fcnther S, Preiser W, van der Werf S, Brodt H-R, Becker S, et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med. 2003;348:1967\u201376.","journal-title":"N Engl J Med"},{"key":"1000_CR9","doi-asserted-by":"publisher","first-page":"100188","DOI":"10.1016\/j.eclinm.2019.10.001","volume":"17","author":"S Watson","year":"2019","unstructured":"Watson S, Caster O, Rochon PA, den Ruijter H. Reported adverse drug reactions in women and men: aggregated evidence from globally collected individual case reports during half a century. EClinicalMedicine. 2019;17:100188.","journal-title":"EClinicalMedicine."},{"key":"1000_CR10","unstructured":"ICH harmonised tripartite guideline post-approval safety data management: definitions and standards for expedited reporting E2D [Internet]. https:\/\/database.ich.org\/sites\/default\/files\/E2D_Guideline.pdf. Accessed 10 Aug 2020."},{"key":"1000_CR11","unstructured":"Medical Dictionary for Regulatory Activities [Internet]. https:\/\/www.meddra.org\/sites\/default\/files\/guidance\/file\/000026_meddra_best_practices_2018_0.pdf. Accessed 22 June 2020."},{"key":"1000_CR12","unstructured":"Miranda D, McMain C, Smith A. Medication-induced QT-interval prolongation and Torsades de Pointes. US Pharm. 2011;36(2):HS-2HS-8."},{"issue":"Issue 1","key":"1000_CR13","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1097\/00001573-199901000-00007","volume":"14","author":"D Wolbrette","year":"1999","unstructured":"Wolbrette D, Patel H. Arrhythmias and women. Current Opinion in Cardiology. 1999;14(Issue 1):36.","journal-title":"Current Opinion in Cardiology"},{"key":"1000_CR14","unstructured":"Public warning on the use of chloroquine\u2019s [Internet]. https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-cautions-against-use-hydroxychloroquine-or-chloroquine-covid-19-outside-hospital-setting-or. Accessed 22 June 2020."}],"container-title":["Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-020-01000-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40264-020-01000-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-020-01000-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T23:22:03Z","timestamp":1632525723000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40264-020-01000-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,25]]},"references-count":14,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1000"],"URL":"https:\/\/doi.org\/10.1007\/s40264-020-01000-8","relation":{},"ISSN":["0114-5916","1179-1942"],"issn-type":[{"value":"0114-5916","type":"print"},{"value":"1179-1942","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,25]]},"assertion":[{"value":"8 September 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No sources of funding were used to conduct this study or prepare this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Alem Zekarias, Sarah Watson, Sara Hedfors Vidlin, and Birgitta Grundmark have no conflicts of interest that are directly relevant to the content of this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The datasets generated and analysed during the current study are not publicly available because of agreements between contributors of data to the database used (VigiBase) and the custodian of this database. National centres (mainly national drug regulatory authorities) constituting the WHO PIDM contribute data to VigiBase, and the Uppsala Monitoring Centre is the custodian in its capacity as the WHO collaborating centre for international drug monitoring. Some subsets of the data may be available from the corresponding author on reasonable request.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of Data and Materials"}},{"value":"Code is unavailable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"All authors contributed to this manuscript.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author Contributions"}}]}}